Selected publications
- Distinctive clinical presentation of a NF-1 patient with loss of heterozygosity of PTCH in his epithelial tumors. International Journal of Dermatology. 2005 Academic Article GET IT
-
Pilot study of low-dose interleukin-2, pegylated interferon-α2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.
Journal of Infectious Diseases.
2005
Academic Article
GET IT
Times cited: 14 -
Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
Archives of Dermatology.
2004
Academic Article
GET IT
Times cited: 10 -
In Vivo assessment of antiviral reactivity in chronic HIV infection.
HIV Clinical Trials.
2000
Academic Article
GET IT
Times cited: 13 -
Low-Dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: A randomized controlled trial.
HIV Clinical Trials.
2000
Academic Article
GET IT
Times cited: 48 -
Immunity restoration of immunity with interleukin-2 therapy.
AIDS Reader.
1999
Review
GET IT
Times cited: 8 -
Interleukin-2 infusions in HIV-infected patients [4].
New England Journal of Medicine.
1997
Article
GET IT
Times cited: 7 - Interleukin-2 therapy for HIV* individuals. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 1996 Academic Article
-
Rational interleukin 2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity.
Proceedings of the National Academy of Sciences of the United States of America.
1996
Academic Article
GET IT
Times cited: 157